VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 58 filers reported holding VERRICA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -41.7% | 3,632 | -12.9% | 0.00% | – |
| Q2 2023 | $24 | -78.2% | 4,172 | -75.3% | 0.00% | – |
| Q1 2023 | $110 | -99.4% | 16,922 | +696.3% | 0.00% | – |
| Q1 2022 | $17,000 | -94.2% | 2,125 | -93.3% | 0.00% | – |
| Q4 2021 | $292,000 | +335.8% | 31,792 | +494.0% | 0.00% | – |
| Q3 2021 | $67,000 | +235.0% | 5,352 | +213.5% | 0.00% | – |
| Q2 2021 | $20,000 | -87.3% | 1,707 | -83.6% | 0.00% | – |
| Q1 2021 | $157,000 | +241.3% | 10,399 | +159.0% | 0.00% | – |
| Q4 2020 | $46,000 | +4.5% | 4,015 | -30.4% | 0.00% | – |
| Q3 2020 | $44,000 | -42.1% | 5,767 | -16.4% | 0.00% | – |
| Q2 2020 | $76,000 | +65.2% | 6,902 | +61.5% | 0.00% | – |
| Q1 2020 | $46,000 | -77.6% | 4,274 | -66.9% | 0.00% | – |
| Q4 2019 | $205,000 | +118.1% | 12,895 | +102.9% | 0.00% | – |
| Q3 2019 | $94,000 | -3.1% | 6,356 | -23.5% | 0.00% | – |
| Q2 2019 | $97,000 | +94.0% | 8,309 | +81.9% | 0.00% | – |
| Q1 2019 | $50,000 | +42.9% | 4,568 | +110.2% | 0.00% | – |
| Q3 2018 | $35,000 | – | 2,173 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 5,038,983 | $19,576,448 | 0.65% |
| BML Capital Management, LLC | 150,000 | $582,750 | 0.54% |
| Caligan Partners LP | 259,593 | $1,009,817 | 0.46% |
| Avoro Capital Advisors LLC | 2,954,064 | $11,476,539 | 0.18% |
| Boxer Capital, LLC | 166,955 | $648,620 | 0.04% |
| SteelPeak Wealth, LLC | 136,986 | $532,191 | 0.03% |
| Legacy Trust | 18,750 | $72,844 | 0.02% |
| Miracle Mile Advisors, LLC | 118,221 | $459,289 | 0.01% |
| SPC Financial, Inc. | 30,000 | $116,550 | 0.01% |
| KORNITZER CAPITAL MANAGEMENT INC /KS | 99,251 | $385,590 | 0.01% |